The ferric enterobactin (FeEnt) receptor CfrA is present in the majority of Campylobacter jejuni isolates and is responsible for high-affinity iron acquisition. Our recent work and that of others strongly suggested the existence of another FeEnt uptake system in Campylobacter. Here we have identified and characterized a new FeEnt receptor (designated CfrB) using both in vitro and in vivo systems. CfrB, a homolog of C. jejuni NCTC 11168 Cj0444, shares approximately 34% of amino acid identity with CfrA. Alignment of complete CfrB sequences showed that the CfrB is highly conserved in Campylobacter. Immunoblotting analysis using CfrBspecific antiserum demonstrated that CfrB was dramatically induced under iron-restricted conditions and was produced in the majority of Campylobacter coli (41 out of 45) and in some C. jejuni (8 out of 32) primary strains from various sources and from geographically diverse areas. All of the CfrB-producing C. coli strains also produced CfrA, which was rarely observed in the tested C. jejuni strains. Isogenic cfrB, cfrA, and cfrA cfrB double mutants were constructed in 43 diverse Campylobacter strains. Growth promotion assays using these mutants demonstrated that CfrB has a major role in FeEnt iron acquisition in C. coli. Chicken colonization experiments indicated that inactivation of the cfrB gene alone greatly reduced and even abolished Campylobacter colonization of the intestines. A growth assay using CfrB-specific antiserum strongly suggested that specific CfrB antibodies could block the function of CfrB and diminish FeEnt-mediated growth promotion under iron-restricted conditions. Together, this work reveals the complexity of FeEnt systems in the two closely related Campylobacter species and demonstrates the important role of the new FeEnt receptor CfrB in Campylobacter iron acquisition and in vivo colonization.
Campylobacter species have emerged as the leading bacterial cause of food-borne human diseases in many industrialized countries since the late 1970s (25) . Two major Campylobacter species, Campylobacter jejuni and Campylobacter coli, cause watery diarrhea and/or hemorrhagic colitis in humans and are also associated with Guillain-Barré syndrome, an acute flaccid paralysis that may compromise respiratory muscle function, resulting in death (24) . In parallel to their increased prevalence, members of Campylobacter have become increasingly resistant to antibiotics, including fluoroquinolones and macrolides, the major drugs of choice for treating human campylobacteriosis (10) . Therefore, development of new strategies to prevent and control Campylobacter infections in humans and animal reservoirs is urgently needed, which greatly relies on the better understanding of Campylobacter pathogenesis.
Despite recent advances in understanding of the pathobiology of C. jejuni (9, 39) , the virulence mechanisms of Campylobacter remain poorly understood. Iron is the most abundant transition metal in living organisms, with critical roles in many diverse biological systems (2); thus, iron acquisition is essential for survival and virulence of pathogenic bacteria in the host (5, 31) . Examination of iron uptake in Campylobacter began in the 1980s (12) , but iron uptake systems, and the associated regulatory systems, in Campylobacter species are now just beginning to be elucidated (reviewed by Miller et al. [22] , Stintzi et al. [34] , and Wooldridge and van Vliet [37] ). Genomic data have shown a large number of genes implicated in iron scavenging, metabolism, storage, and regulation in C. jejuni (22, 34, 37) . Several iron uptake systems have been identified and characterized (22, 34) ; among these, the ferric enterobactin (FeEnt) iron acquisition system is of particular interest because enterobactin (Ent) has the highest affinity for ferric iron of any natural siderophore compound tested (35) . Furthermore, Ent is produced by a wide variety of commensal bacteria in the intestines, and this compound is likely to be produced in significant amounts by the resident microflora in the gut (37) . Thus, FeEnt may be a significant source of iron for Campylobacter species during intestinal colonization even though Campylobacter species do not appear have the capacity to synthesize Ent (34) .
A FeEnt acquisition system in C. jejuni was identified which comprises an outer membrane receptor, CfrA, and cognate components, including a TonB-ExbB-ExbD protein complex and an ABC transporter system CeuBCDE (22, 34) . The FeEnt receptor CfrA is induced under iron-restricted conditions and plays a critical role in iron acquisition and in vivo colonization by C. jejuni (27) . A recent report (40) provides further molecular, antigenic, and functional evidence suggesting that CfrA is a promising subunit vaccine for preventing and controlling C. jejuni infection in humans and animal reservoirs.
Interestingly, in this study one C. jejuni strain (JL11), which does not have a gene highly homologous to cfrA, could efficiently utilize FeEnt as a sole iron source for growth (40) . An early study also showed that an isogenic cfrA mutant of a human C. coli strain was still fully capable of utilizing FeEnt as a sole iron source for growth (15) . These studies strongly suggest that Campylobacter species possess an additional system for FeEnt-mediated iron acquisition.
In this study, we demonstrate that a homolog of the C. jejuni NCTC 11168 protein Cj0444 (28) is a FeEnt receptor, designated CfrB, in Campylobacter. CfrB is highly conserved among members of Campylobacter and plays an important role in the colonization of the intestine by both C. jejuni and C. coli.
MATERIALS AND METHODS
Bacterial strains, plasmids, and culture conditions. The major bacterial strains and plasmids used in this study are listed in Table 1 . Among the 77 strains used for a survey of prevalence and function, 32 isolates were C. jejuni while 45 isolates were C. coli. For the C. jejuni strains, the majority of them (30 out of 32) were described and used in our previous CfrA study (40) , and 2 new human isolates were used in this study. The C. coli strains were isolated from human (5 isolates), bovine (10 isolates), swine (18 isolates), chicken (11 isolates), and turkey (1 isolate) samples. All of these Campylobacter strains were obtained from geographically diverse areas. The Campylobacter strains were routinely grown in Mueller-Hinton (MH) broth (Difco, Sparks, MD) or on agar at 42°C under microaerobic conditions, which were generated using a CampyGen Plus (Oxoid, Hampshire, England) gas pack in an enclosed jar. When iron-rich conditions were required, medium was supplemented with 40 M ferric sulfate. When iron-limited conditions were needed, medium was supplemented with 20 M deferoxamine mesylate (DFO). Escherichia coli was grown in Luria-Bertani (LB) broth with shaking (250 rpm) or on agar at 37°C overnight. When needed, culture media were supplemented with ampicillin (Amp; 100 g/ml), kanamycin (Kan; 30 g/ml), or chloramphenicol (Cm; 6 g/ml).
PCR analysis. Major PCR primers used in this study and the expected sizes of the products are listed in The complete open reading frame (ORF) of cfrB from C. jejuni was PCR amplified using primer pairs of JCfrBF and JCfrBR, while the complete ORF of cfrB from C. coli was PCR amplified using primer pairs CCfrBF and CCfrBR ( Table 2 ). The purified PCR products of cfrB were subjected to sequencing and alignment. To identify the phylogenetic relationship between CfrB and CfrA, multiple sequence alignment among CfrB and CfrA sequences from different Campylobacter strains was performed using the ClustalW program in MEGA 4.0 (19) . The dendrogram was constructed by neighbor-joining methods in MEGA 4.0 (19) . To predict the secondary structure of CfrB, the amino acid sequence of CfrB was analyzed by using the program TransMembrane protein re-presentation in 2 dimensions tool (TMRPres2D) (33) . To identify the conserved amino acids that may play a critical role in FeEnt binding, multiple sequence alignment of the CfrB and CfrA sequences from different Campylobacter strains was performed using the ClustalW2 program (http://www.ebi.ac.uk/Tools/clustalw2/index.html).
Construction of isogenic cfrB mutants and complementation in trans. We first constructed a deletion mutation in cj0444, a pseudogene in C. jejuni NCTC 11168 with high homology to cj81176_0471 of C. jejuni 81-176 (designated cfrB in this study). Briefly, two separate fragments of the coding sequence of cj0444 and its flanking regions were PCR amplified from NCTC 11168 using the primer pairs Cj0444-1/Cj0444-2 and Cj0444-3/Cj0444-4 ( Table 2 ). These two PCR fragments were digested with corresponding enzymes (SstI, BamHI, and HindIII) ( Table 2) and cloned into plasmid pUC18NotI that had been digested with SstI and HindIII; approximately 2,000 bp of the cj0444 internal region was deleted. A Cm or Kan resistance gene was then inserted, in the forward orientation with respect to the gene, into the BamHI site created by the deletion, resulting in plasmids pRDH204 and pRDH207, respectively ( Table 1 ). The plasmid constructs, which served as suicide vectors, were transferred into C. jejuni 81-176 by electroporation. One Cm-resistant mutant (JL366) and one Kan-resistant mutant (JL364) were selected on selective MH agar plates. Inactivation of the cj0444 gene was confirmed by PCR (data not shown). Notably, despite cj0444 being a pseudogene in C. jejuni NCTC 11168, the PCR fragments obtained using 11168 genomic DNA as a template are almost identical to the corresponding sequences of most C. jejuni strains, including C. jejuni 81-176 and JL11 over the regions used (data not shown). Thus, an isogenic cfrB mutant of C. jejuni JL11 (JL411) ( Table 1) was then easily obtained by standard natural transformation as described by Wang and Taylor (36) using purified genomic DNA from JL364.
An isogenic cfrB mutant of C. coli JL170 was constructed by using the same insertional mutagenesis strategy as described previously (40) . Briefly, based on the published genome sequence of C. coli RM2228 (13), primers CCfrBF and CCfrBR (Table 2) were designed for successful amplification of a 2.7-kb cfrB fragment from C. coli JL170. The PCR product with a unique EcoRV restriction site was cloned into pGEM-T Easy vector (Promega), resulting in the construct pCB. The Cm resistance gene was amplified from plasmid pUOA18 (36) with primers CHLF1 and CHLR1 using PfuTurbo DNA polymerase (Stratagene). The 0.8-kb PCR product containing a Cm resistance gene was ligated to EcoRVdigested pCB to obtain the construct pmCB. Sequence analysis of the construct indicated that the Cm resistance cassette was inserted into cfrB with the same transcriptional direction. The plasmid pmCB, which served as a suicide vector, was transferred into C. coli JL170 by natural transformation. The isogenic cfrB mutant, named JL500 (Table 1) , was selected on MH agar containing 6 g/ml of Cm. The inactivation of the cfrB gene in JL500 was confirmed by PCR (data not shown).
To complement cfrB inactivation in Campylobacter, a 2.3-kb fragment spanning from the promoter region of cfrB to 90 bp downstream of the cfrB stop codon was amplified from 81-176 using primers JCfrBF and JCfrBR ( Table 2 ). The PCR analysis was performed using Pfu Turbo DNA polymerase (Stratagene), and the PCR product was purified and inserted into the shuttle vector pRY107 digested with SmaI. The ligation mix was introduced into strain DH5␣ by transformation. A transformant with a plasmid construct bearing the intact cfrB gene (named pCfrB) was identified (JL463). The pCfrB plasmid from strain JL463 was then transferred to JL324 (Table 1) by triparental conjugation (40) , creating the construct JL465 (Table 1) .
To determine the role of CfrB in FeEnt acquisition and the relative contributions of CfrA and CfrB in FeEnt assimilation in Campylobacter, the cfrB mutants, cfrA mutants, and cfrA cfrB double mutants of various Campylobacter strains were constructed for FeEnt growth promotion assays. To construct isogenic cfrB mutants, the insertional mutations of cfrB in C. coli JL500 and C. jejuni JL366 were introduced into C. coli and C. jejuni strains, respectively, by natural transformation. The genomic DNA extracted from JL324 (Cm resistant) or JL492 (Kan resistant) was used to construct isogenic CfrA mutants for all Campylobacter isolates using natural transformation. To construct cfrA cfrB double mutants of C. jejuni strains, the genomic DNA of JL364 (⌬cfrB::kan) was used to transform the cfrA::cat mutant. To construct the cfrA cfrB double mutant of C. coli strains, the genomic DNA of JL492 (cfrA::kan) was used to transform the corresponding cfrB::cat mutant. All mutant constructs of Campylobacter isolates were confirmed by PCR analysis and immunoblotting using anti-CfrB antibodies (see below).
Growth promotion assay. The ability of Campylobacter to use FeEnt as a sole iron source for growth was assessed using standard growth promotion assay as described in our previous publication (40) . Briefly, Campylobacter log-phase cells grown in MH broth (ϳ2 ϫ 10 7 cells) were mixed with melted MH agar containing the chelator DFO at final concentration of 20 M. The mix was immediately (40). Production of recombinant CfrB and generation of polyclonal antisera. A CfrB region that is highly conserved in CfrB but shares low homology to CfrA was chosen for production of rCfrB. A histidine-tagged rCfrB was produced in E. coli by using the pQE-30 vector of the QIAexpress expression system (Qiagen). Briefly, a 609-bp fragment covering a 197-amino acid (aa) region of CfrB (aa 194 to 390) was PCR amplified from C. jejuni JL11 using the primer pairs CfrBEF and CfrBER ( Table 2 ). The amplified product and the vector pQE30 (Table 1) were both digested with BamHI and HindIII and ligated with each other. Cloning, expression, and purification of rCfrB peptide were performed using the procedures described in our previous publication (40) . The plasmid pCfrB-NHIS in the E. coli JM109 clone (JL470) producing rCfrB was sequenced, and no mutations in the coding sequence of cfrB were detected. Approximately 3 mg of highly purified rCfrB was used for the production of rabbit polyclonal antisera against CfrB by Pacific Immunology Corp. (Ramona, CA). Pre-and postimmune serum samples were analyzed by immunoblotting, using both the rCfrB and the whole-cell lysate of C. jejuni JL11 grown under iron-restricted conditions. SDS-PAGE and immunoblotting. The whole-cell lysates of various Campylobacter strains and mutant constructs, grown under different conditions, were prepared for SDS-PAGE and immunoblotting analysis using anti-CfrB and antiCfrA antibodies as described previously (40) .
Inhibition of CfrB-mediated FeEnt utilization by CfrB antiserum. The ability of specific CfrB polyclonal antiserum to inhibit CfrB-mediated FeEnt assimilation in C. coli JL170 and C. jejuni JL11 was assessed using a modified growth promotion assay (40) . Prior to the assay, the CfrB-specific rabbit antiserum, the preimmune control rabbit serum, and the major outer membrane protein (MOMP) rabbit antiserum specific for Campylobacter (kindly provided by Qijing Zhang, Iowa State University) were heat inactivated at 56°C for 30 min. To evaluate the inhibitory effect of anti-CfrB serum on CfrB function, 1 ml of MH broth grown log-phase culture of each Campylobacter strain was mixed with 1 ml of either CfrB antiserum, preimmune serum, MOMP antiserum, or phosphatebuffered saline (PBS) and then added to 23 ml of MH agar containing 20 M DFO and poured into petri dishes for solidification. A sterile disk containing 10 l of Ent (5 mM) was placed on the surface of the agar in each dish. The growth zone around the disk was observed after 24 h of incubation at 42°C under microaerobic conditions.
Chicken colonization experiment. One-day-old broiler chickens were obtained from a commercial hatchery (Hubbard Hatchery, Pikesville, TN). The chickens were negative for Campylobacter as determined by culturing cloacal swabs prior to use in this study. In a pilot competition experiment, two groups of 4-day-old chickens (15 birds/group) were orally inoculated with a 1:1 mixture of C. jejuni JL11 and its isogenic cfrB mutant JL411 (group 1), or with a 1:1 mixture of C. coli JL170 and its isogenic cfrB mutant JL500 (group 2), with a dose of approximately 10 7 CFU of bacteria per bird. Fecal samples were collected using cloacal swabs, which were taken at 5 and 10 days postinoculation (DPI). Each fecal suspension was diluted and duplicate plated onto MH agar plates with Campylobacterspecific selective supplements (Oxoid, United Kingdom) for total Campylobacter enumeration and onto selective plates supplemented with the appropriate antibiotic (30 g/ml of Kan or 6 g/ml of Cm) for enumeration of the cfrB mutants in each sample. The plating media were tested prior to use to ensure that they supported the growth of the mutant strains. Notably, before inoculation, the motility of the wild type and its isogenic cfrB mutant was confirmed to be at a comparable level.
In the second experiment, three groups of 4-day-old chickens were inoculated with C. coli JL170 (group 1), JL500 (group 2), and a 1:1 mixture of these two strains (group 3). Inoculation was also performed via oral gavage using a dose of approximately 10 7 CFU of bacteria per bird. For each group, six birds were euthanized and cecal contents were collected at 3, 6, or 10 days postinoculation. The cecal contents from each bird were weighed and diluted in MH broth. The diluted samples were cultured on MH agar plates with Campylobacter-specific selective supplements (Oxoid, United Kingdom) for colony counting. For the group 3 cecal samples, duplicate plating of each sample was performed as described above to determine the total number of Campylobacter and cfrB mutant isolates for each sample. This chicken experiment was conducted twice with the same design.
The number of CFU per gram of cecal contents was calculated for each chicken and was used as an indicator of the colonization level. The detection limit of the plating methods was 100 CFU/g of cecal contents. A bird from which no Campylobacter colonies were detected was assigned a conservative value of 99 CFU/g of cecal contents for the purpose of calculating means and for statistical analysis. Student's t test was used to examine the significance of differences in Campylobacter colonization levels (log transformed CFU). A P value of Ͻ0.01 was considered significant.
Nucleotide sequence accession numbers. The full coding sequences of cfrB of C. jejuni (JL11 and JL105) and C. coli (JL170, GR3, GR7, QZ7) as well as the cfrA sequence of JL170 have been deposited into GenBank under the accession numbers GU952792 (JL11_CfrB), GU952793 (JL105_CfrB), GU952794 (JL170_CfrB), GU952795 (JL170_CfrA), HM130672 (GR3_CfrB), HM130673 (GR7_CfrB), and HM130674 (QZ7_CfrB).
RESULTS

Identification of the new FeEnt receptor CfrB in
Campylobacter. Our recent study (40) showed that C. jejuni 81-176 (JL242) expressed a protein band that reacted with antibodies directed against CfrA even though the genome sequence of 81-176 does not encode CfrA (16) . BLAST searches revealed Cjj81176_0471, a homolog of Cj0444 of NCTC 11168, as a putative iron-regulated OMP sharing 34% aa identity and 54% aa similarity with CfrA. As shown in Fig. 1A , inactivation of Cjj81176_0471 completely abolished production of the specific band observed in the wild-type strain 81-176, indicating that the Cj0444 homolog is an iron-regulated OMP that crossreacts with CfrA antibodies. The molecular and functional (Fig. 1B) . Interestingly, our CfrA prevalence study (40) identified a C. jejuni strain, JL11, which also lacks CfrA but which can still effectively utilize FeEnt; JL11 produces a band that cross-reacts with CfrA-specific antibodies in a manner similar to 81-176 (Fig. 1A) . PCR analysis using cfrB-specific primers demonstrated that JL11 contains a cfrB homolog gene (data not shown). The cfrB isogenic mutant of JL11, transferred from the 81-176 cfrB deletion mutant by natural transformation, failed to produce the band cross-reactive with CfrA antibodies under iron-restricted conditions (Fig. 1A) . More importantly, inactivation of the CfrB homolog gene completely abolished the ability of JL11 to utilize FeEnt as a sole iron source for growth (Fig. 1B) . Notably, the deletion mutation of cfrB did not cause a polar effect on the gene downstream of the CfrB gene in JL11 (a putative NUDIX hydrolase family protein gene homologous to cj0447) as indicated by reverse transcription-PCR (RT-PCR) analysis (data not shown). Thus, the defect of the isogenic cfrB mutant of JL11 for FeEnt utilization is directly linked to the function of CfrB, which indicates that CfrB is a new FeEnt receptor in Campylobacter.
C. coli JL170 appears to produce both CfrA and CfrB (40) . Interestingly, insertional inactivation of CfrA in JL170 did not affect the ability of this strain to utilize FeEnt as the sole iron source for growth (Fig. 1B) ; this is consistent with an earlier report in which the cfrA mutant of a human C. coli strain VC167T1 was still able to utilize FeEnt (15) . These findings further suggested that these C. coli strains contain a FeEnt receptor in addition to CfrA. PCR analysis using primers specific to 81-176 cfrB demonstrated the presence of cfrB in JL170 (data not shown). However, we were unable to create an isogenic cfrB mutant of JL170 by natural transformation when using genomic DNA from the cfrB mutant of C. jejuni 81-176; this is possibly due to sequence variation between C. jejuni and C. coli. To solve this problem, we designed primers using the cognate gene product (CCO0537; 86% aa identity with CfrB) of C. coli RM2228 (13) and amplified, cloned, and then inactivated cfrB from JL170 by insertional mutagenesis to create the mutant JL500 ( Table 1 ). The mutation of CfrB in JL500 was confirmed by PCR (data not shown) and immunoblot (Fig.  1A) analyses using CfrB-specific antiserum. As shown in Fig.  1B , inactivation of CfrB alone in JL170 abolished the FeEntmediated growth promotion, thereby demonstrating that CfrB plays the dominant role in FeEnt acquisition in a C. coli strain that produces both CfrA and CfrB receptors.
As mentioned above, the homolog of the cfrB gene in C. jejuni NCTC 11168 was annotated as a pseudogene (cj0444) (28) . Mutation of NCTC 11168 cfrA completely abolished its ability to utilize FeEnt for growth; however, complementation of this mutant with the wild-type cfrB gene fully rescued the defect (Fig. 1B) and was correlated with the production of CfrB in this complemented construct (Fig. 1A) . Together, the findings described above provide compelling additional evidence that CfrB is a new FeEnt receptor that is functional in both C. jejuni and C. coli.
Sequence and predicted structure comparison between CfrB and CfrA. The full-length cfrB genes from C. jejuni strains (JL11 and JL105) and C. coli strains (JL170, GR3, GR7, and QZ7) were sequenced in this study. The new sequences were translated into deduced protein sequences and aligned with the CfrB sequences from 8 Campylobacter strains (7 C. jejuni and 1 C. coli) and the CfrA sequences from 18 Campylobacter strains (15 C. jejuni and 3 C. coli) deposited in the NCBI public database (http://www.ncbi.nlm.nih.gov/sutils/genom_table.cgi). ClustalW analysis in MEGA 4.0 divided the CfrB and CfrA sequences into two distinct groups with approximately 31% amino acid identity between these two groups ( Fig. 2A) . Although CfrB sequences displayed a high level of homology among various Campylobacter strains, phylogenetic analysis resulted in two clusters for CfrB (Fig. 2A) . The levels of aa identity for CfrB within each cluster range from 94% to 99%, while the CfrB sequences between cluster 1 and cluster 2 share lower homology, with aa identity ranging from 84% to 87%. Interestingly, the CfrB sequences in cluster 1 were all derived from C. coli and those in cluster 2 were all from C. jejuni ( Fig.  2A) . The sequence analysis also revealed that CfrA and CfrB could coexist in both C. jejuni and C. coli strains (e.g., C. jejuni 260.94 and C. coli JL170) ( Fig. 2A) , which is consistent with our previous finding from a CfrA prevalence study (40) and is further demonstrated by the comprehensive molecular survey described below.
Similar to the proposed structures of FeEnt receptors CfrA (6, 40) and FepA (4, 23), the secondary structure prediction of CfrB is composed of two domains, a conserved N-terminal globular plug domain and a 22-stranded ␤-barrel domain at the C terminal (data not shown). The predicted ␤-barrel exhibits long loops on the external side of the membrane and short turns facing the periplasmic space. As expected, several structural motifs conserved in FeEnt receptors (e.g., the Ton box, TEE, PGV, IRG, LIDG, and RP) (6, 7) were also identified in the highly conserved N-terminal globular plug domain of CfrB by multiple sequence alignment (data not shown). Given that CfrA and CfrB share the same function for FeEnt acquisition and a similar secondary structure, we were particularly interested in the regions, epitopes, and even amino acids that are highly conserved between CfrA and CfrB with respect to functionality. Specific emphasis was placed on the sequence covering the third to fifth extracellular loops that have been demonstrated as responsible for ligand binding in previous immunological, structural, and mutagenesis analyses of FeEnt receptors (4, 23, 30, 40) . As shown in Fig. 2B , the sequence of the potential FeEnt binding region displays great variation between CfrA and CfrB, although it is highly conserved within each specific type of FeEnt receptor. The length of corresponding loops varied greatly between CfrA and CfrB (Fig.  2B) ; however, CfrA and CfrB share several conserved amino acids that may contribute to the binding of substrate FeEnt, including the positively charged amino acids K and R and the aromatic amino acid Y (Fig. 2B) . The essential role of R327 in CfrA-mediated FeEnt assimilation has been demonstrated in our recent work (40) .
Both CfrB and CfrA coexist and are widely produced in C. coli isolates. To determine the prevalence of CfrB in Campy- VOL. 192, 2010 NEW FERRIC ENTEROBACTIN RECEPTOR CfrB 4429
lobacter, a recombinant CfrB peptide, whose region is highly conserved in CfrB but shares low homology to CfrA, was produced in an E. coli construct and purified by a Ni-nitrilotriacetic acid (Ni-NTA) agarose affinity column for preparation of CfrB-specific antibodies (Fig. 3A) . The highly purified rCfrB was used for production of rabbit polyclonal antisera against CfrB. As expected, the CfrB antiserum specifically recognized CfrB without cross-reaction with CfrA (see Fig. 1A for JL170 and its derivatives). Using CfrB-and CfrA-specific antibodies, we comprehensively examined the production and prevalence (40) and the public database NCBI (http://www.ncbi.nlm.nih.gov/). For the CfrB sequences, the strains with the prefix "JL" were used for cfrB gene amplification and sequencing in this study, and the complete cfrB sequences of these strains have been deposited in GenBank. A strain with a label of "(2)" following its name indicates that this strain not only produces CfrB but also produces a CfrA protein that was included in the CfrA analysis. (B) Prediction of potential regions and amino acids in CfrB and CfrA important for FeEnt binding. The extracellular loops 3, 4, and 5 were predicted and shown for CfrB (above the alignment) and CfrA (below the alignment). The conserved amino acids that might contribute to FeEnt assimilation are enclosed in boxes. The conserved amino acids that may involve ligand binding and their locations are indicated by solid arrows above the alignment for CfrB and below the alignment for CfrA.
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of CfrB and CfrA among 32 C. jejuni isolates and 45 C. coli isolates from multiple sources and from geographically diverse areas. Based on immunoblotting analysis, the majority of C. coli isolates (41 out of 45) produced both CfrB and CfrA (Table 3) . Taking the 11 poultry C. coli strains as an example, each of these C. coli strains produced CfrB that strongly reacted with CfrB-specific antibodies, while insertional inactivation of the cfrB gene completely aborted the production of CfrB (Fig. 3B, top) . Immunoblotting analysis using CfrA antibodies (Fig. 3B, bottom) clearly indicated that each strain also produces CfrA and that the CfrA antibody also detected a smaller-molecular-weight CfrB band in each wild-type strain (a faint band indicated by an arrow). These 11 C. coli strains were isolated from chickens in 5 different U.S. states, strongly indicating that CfrA and CfrB are widely distributed and coproduced in the C. coli isolates from poultry. In contrast to the findings for C. coli strains, only 1 C. jejuni strain produced both CfrA and CfrB in our survey (Table 3) . Despite the high prevalence of CfrB and CfrA in C. coli, interestingly, there was no C. coli isolate observed to produce CfrB only, while 4 C. coli strains from swine produced CfrA only (Table 3) . Consistent with our previous survey (40) , the majority of C. jejuni isolates produced CfrA only; however, a small population of C. jejuni strains (7 out of 32) were observed that produced only the newly identified CfrB (Table 3) . It is important to mention that the species-level identity of each Campylobacter strain used in this survey has been confirmed by PCR using species-specific primers as described previously (26 and data not shown). Together, this survey strongly suggests that CfrB and CfrA coexist and are widely produced in C. coli, but it also reveals the complexity of the prevalence and evolution of these two FeEnt receptors in two closely related Campylobacter species.
CfrB has an important role in FeEnt iron acquisition in C. coli. The isogenic cfrB, cfrA, and cfrA cfrB double mutants were successfully constructed in more than half of the Campylobacter strains that were used for the prevalence survey (Table  3) . For the strains producing both CfrA and CfrB, inactivation of CfrB alone dramatically reduced FeEnt usage while mutation of CfrA alone had little effect on growth promotion in the majority of the tested strains (Table 4) . Inactivation of both CfrA and CfrB completely abolished the ability of these C. coli strains to use FeEnt as a sole iron source for growth (Table 4) . However, the opposite finding that CfrA rather than CfrB plays a dominant role in FeEnt assimilation was observed for a very small population (2 C. coli isolates from swine and 1 C. jejuni isolate from chicken) ( Table 4) . Intriguingly, for the three bovine C. coli strains which showed a FeEnt growth (2) were grown in iron-restricted MH broth, and whole-cell lysates were separated on SDS-PAGE gel prior to immunoblotting analysis using CfrB-and CfrA-specific antibodies. The arrows in the bottom panel show the CfrB band that cross-reacted with the CfrA antibody in each wild-type strain. a Production of CfrA and CfrB in primary Campylobacter strains was determined by immunoblotting using specific antibodies as described in Materials and Methods. The strains could produce both CfrA and CfrB (CfrA ϩ CfrB), CfrA only (CfrA), or CfrB only (CfrB).
b The isolates were from samples from different farm environments, including lagoon water, bird droppings, and mouse traps.
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promotion (zone diameter, 1.46 Ϯ 0.16 cm) that was weaker than that of most wild-type strains (4.14 Ϯ 0.20 cm), inactivation of CfrA alone completely abolished the FeEnt utilization, whereas inactivation of CfrB alone significantly increased the ability of these strains to utilize FeEnt as a sole iron source for growth (2.77 Ϯ 0.29 cm) ( Table 4 ). This interesting finding has been repeated in three independent experiments. Most of the Campylobacter strains that produced CfrA only could utilize FeEnt efficiently; inactivation of CfrA abolished the FeEnt-mediated growth promotion (Table 4) . CfrA was also essential for FeEnt acquisition in a C. jejuni human strain that showed a weak growth zone in the presence of FeEnt (Table 4 ). The survey also identified one human C. jejuni strain that produced CfrA but still failed to utilize FeEnt as a sole iron source for growth. For the one C. jejuni strain (JL11) that produced CfrB only, CfrB is essential for FeEnt-mediated growth promotion (Table 4 and Fig. 1) . Interestingly, we identified five human C. jejuni strains, including the commonly used strain 81-176, which produced CfrB but failed to utilize FeEnt for growth (Table 4) . 
a Production of CfrA and CfrB in primary Campylobacter strains was determined by immunoblotting using specific antibodies. CfrA ϩ CfrB, both CfrA and CfrB produced in a single strain; CfrA, only CfrA produced in a single strain; CfrB, only CfrB produced in a single strain. 
CfrB is required for Campylobacter colonization in chickens.
In a pilot experiment (Fig. 4A) , inactivation of the cfrB gene greatly impaired the colonization ability of a C. jejuni strain (JL11) and a C. coli strain (JL170) in chickens. Specifically, when the wild type and its isogenic cfrB mutant were coinoculated into a group of chickens, the colonization level of the cfrB mutant was significantly (P Ͻ 0.01) lower than that of the corresponding wild-type strain at 5 and 10 days postinoculation (DPI). In particular, by 10 DPI, the cfrB mutant of JL170 was no longer detected in any of the cloacal samples collected from the chickens inoculated with mixture of JL170 and its cfrB mutant (Fig. 4A) . Notably, both the wild type and its cfrB mutant showed comparable growth patterns in MH broth (data not shown). In addition, an identical in vitro competition assay in MH broth culture was also performed; the cfrB mutant displayed an in vitro competitive index (ratio of the mutant to the wild-type strain at early stationary phase) of approximately 1, further indicating that inactivation of the cfrB gene did not affect its growth rate compared to that of the wild-type strain.
A more dynamic and quantitative chicken experiment was performed to evaluate the role of CfrB in colonization by JL170, the strain producing both CfrA and CfrB. When inoculated alone into chickens, the wild-type strain JL170 colonized the majority of birds as early as 3 DPI and colonized all chickens by 6 DPI, with levels as high as 10 10 CFU/g of cecal contents (Fig. 4B) . In contrast, the isogenic cfrB mutant failed to colonize any individual chickens throughout the study (Fig.  4B ). In the competitive colonization group (Fig. 4C) , wild-type JL170 also colonized all of the chickens, with levels ranging from 10 8 to 10 10 CFU/g of cecal contents throughout the study, while the mutation of CfrB abolished the colonization ability of JL170 in the intestines. This finding has been reproduced in a second independent chicken experiment with the same design (data not shown).
CfrB-specific antiserum inhibited FeEnt-mediated growth promotion. Since CfrB is an iron-regulated outer membrane protein that plays a critical role in FeEnt acquisition and in chicken colonization, we speculate that it may be an attractive target for immune intervention against Campylobacter. As Fig. 4D , CfrB-specific antiserum completely inhibited FeEnt-mediated growth promotion in both C. jejuni JL11 and C. coli JL170, whereas the MOMP antiserum, preimmune serum, and PBS did not significantly affect the FeEnt-mediated growth promotion in these strains (Fig. 4D) .
DISCUSSION
FeEnt iron acquisition is a major and consequently the best examined siderophore-mediated high-affinity iron uptake system in Gram-negative bacteria (11, 30) . Because FeEnt is too large to pass through the bacterial outer membrane porin channels, it requires a specific iron-regulated OMP to enable its passage across the outer membrane for further transportation and subsequent Fe utilization (2) . Therefore, the outer membrane FeEnt receptor functions as a critical "gatekeeper" for FeEnt iron assimilation in bacteria. It has been observed that some Gram-negative bacteria can produce several receptors for FeEnt-mediated iron utilization (14, 29) . CfrA has previously been identified as the FeEnt receptor involved in iron acquisition in C. jejuni (15, 27, 40) . In this study, we provide compelling evidence for the identification of a new, alternative FeEnt receptor, CfrB, in Campylobacter. First, in C. jejuni strain JL11, which does not have a cfrA gene (40), inactivation of the cfrB gene (a homolog of cj0444) fully abolished its ability to utilize FeEnt as a sole iron source for growth (Fig.  1) . Second, in C. jejuni NCTC 11168, in which CfrA plays an essential role in FeEnt-mediated iron acquisition (27, 40) , complementation of an isogenic cfrA mutant with the fulllength cfrB gene in trans fully restored the ability of the mutant to utilize FeEnt (Fig. 1) . Finally, mutation of the cfrB gene alone in C. coli JL170 (Fig. 1 ) or in other diverse C. coli strains (Table 4) greatly impaired the ability of these strains to utilize FeEnt even if the CfrA was coproduced within the same strain. These findings, plus the fact that the CfrB shows homology with CfrA ( Fig. 2A) , strongly indicate that CfrB is a different FeEnt receptor in Campylobacter.
Interestingly, the widely studied C. jejuni strain 81-176 was unable to utilize FeEnt (16, 40) even though this strain could express and produce functional CfrB under iron-restricted conditions (Fig. 1) . Given that FeEnt acquisition is a process which involves multiple components from the outer membrane to the cytoplasm (2, 18), we speculate that 81-176 may lack an essential component(s) in the pathway, thereby leading to its inability to utilize FeEnt. Similar to that in other Gram-negative bacteria, the FeEnt iron uptake system in C. jejuni is composed of an outer membrane receptor and other cognate components, such as TonB-ExbBD (energy transduction system) and CeuBCDE (ABC transporter system) (22, 34) . Some C. jejuni strains, such as NCTC 11168, contain three TonBExbBD systems (16, 28) , whereas the genome sequence of 81-176 revealed just a single energy transduction system (TonB2/ExbB2/ExbD2) as well as CeuBCDE (16) . Using highly specific PCR primers targeting these cognate component genes, we observed that JL11, a C. jejuni strain which displays an exceptional ability to use FeEnt for growth (Fig. 1) , shared known components of the FeEnt acquisition systems that are identical to those of 81-176; i.e., one FeEnt receptor, CfrB; one tonB homolog and its associated components (TonB2/ExbB2/ExbD2); and CeuBCDE (see Table S2 in the supplemental material). Thus, we speculate that JL11 contains an unidentified additional component that is missing in 81-176 but essential for CfrB-dependent FeEnt acquisition. In addition, since complementation of the isogenic cfrA mutant of NCTC 11168 with the wild-type cfrB gene completely rescued the defect of the mutant for FeEnt utilization (Fig. 1) , it is probable that NCTC 11168 contains the same novel component for CfrB-mediated FeEnt acquisition. Thus, whole-genome sequencing of JL11 and subsequent comparative genomic analysis of JL11, 81-176, and NCTC 11168, in conjunction with the available transcriptome profiling of C. jejuni in response to iron (17, 27) , could provide insight into the molecular interactions of CfrB-mediated FeEnt acquisition and may solve the puzzle as to why 81-176 is unable to utilize FeEnt despite the production of functional CfrB and its major cognate components for transportation. This hypothesis is being investigated in our laboratory.
Iron is pivotal in the host-pathogen relationship (31) . Therefore, possession of iron uptake systems and functional ironregulated OMPs is essential for bacterial survival and virulence in vivo. Bacteria have evolved complex and redundant iron uptake systems which coordinate with each other and fulfill the need for their growth (2, 18) . The chicken experiments in this study show that inactivation of the cfrB gene alone greatly reduced and even abolished colonization of chickens by Campylobacter; this indicates that CfrB plays an important role in the colonization of the intestines by Campylobacter species which cannot be effectively compensated by other iron uptake systems. It has been previously demonstrated that CfrA plays a critical role in iron acquisition and pathogenesis in C. jejuni strains that produce CfrA only (27, 40) . However, both the in vitro and in vivo work in this study strongly suggest that CfrB is the dominant player in both FeEnt utilization and in vivo colonization in Campylobacter strains that produce both CfrA and CfrB; inactivation of the cfrB gene could not be effectively rescued even by the presence of a functional cfrA gene in the chromosome (Table 4 and Fig. 4 ). CfrB may have other functions in infection in addition to FeEnt usage; for example, CfrB also shows homology to the Iha protein (30% aa identity), which functions both in FeEnt acquisition and in adherence to host cells (20) . It would be interesting to determine if CfrB also plays a role in adherence to host cells. In addition, our recent study (40) showed that CfrA is involved in norepinephrine (NE)-mediated growth promotion and may be required for C. jejuni to sense intestinal stress hormones during colonization. However, in this study, CfrB was not involved in NE-mediated growth promotion in Campylobacter (see Fig. S1 in the supplemental material); this is likely due to the inability of CfrB to take up NE and/or deficiency in the cognate components downstream of CfrB for NE sensing and acquisition.
Since CfrB plays an important role in the in vivo colonization of Campylobacter, it is tempting to speculate that CfrB may be used as a novel subunit vaccine candidate for immune intervention against Campylobacter. Our results clearly show the effectiveness of CfrB-specific antiserum for inhibiting FeEnt-mediated growth promotion of Campylobacter under iron-limited conditions (Fig.  4C) , suggesting that the antibodies may physically block the binding of FeEnt to the ligand binding site of CfrB. Multiple sequence analysis has identified the regions and specific amino acids in CfrB that are likely to be important for FeEnt binding (Fig. 1B) .
Testing these predictions by identification of conserved protective epitopes in CfrB using site-directed amino acid substitution mutagenesis (40) would provide critical information for the future design of an effective subunit vaccine. The feasibility of targeting CfrA for immune protection against C. jejuni has been demonstrated (40) . The sequence variation between the two highly conserved FeEnt receptors CfrB and CfrA suggests that a divalent subunit vaccine might be developed to confer full protection against both C. jejuni and C. coli. Notably, a recent study (32) showed that C. coli and C. jejuni are converging as a consequence of the increased genetic changes within these two species, which further supports the feasibility and significance for developing a FeEnt receptor-based subunit vaccine against Campylobacter. On the other hand, given this convergence of C. jejuni and C. coli (32) and the complex distribution of CfrA and CfrB in these two closely species observed here and previously (40) , FeEnt acquisition systems may serve as a model system for us to study the evolution of iron acquisition and pathogenesis in Campylobacter.
